Top Links

Articles Related to metastasis

Thyroid Cancer Incidence and Clinicopathological Differences in Patients with End-Stage Renal Failure

Aim: In the present study we aimed to determine the prevalence of thyroid cancer and the clinicopathological properties of papillary thyroid cancer (PTC) in a patient population undergoing dialysis for end-stage renal failure (ESRF). Material and Methods: We retrospectively reviewed all thyroid ultrasonography (USG) examinations performed between January 2007 and December 2015 to determine the incidence of nodular thyroid disease in ESRF and normal patient populations. For both patient groups, differences between patient and tumor characteristics were evaluated in patients diagnosed to have PTC.
View complete article: PDF  |  Full-text

Scalp, Skull, Lung and Bone Metastasis from Follicular Thyroid Carcinoma - A Rare Case Report

Concurrent scalp, skull, lung and bone metastasis from follicular thyroid carcinoma is a very rare event. We herein present the case of a 37- year’s old lady, who presented to us with huge scalp swelling that proved to be metastasis from a follicular thyroid carcinoma. The metastatic workup disclosed bilateral lung metastasis and additional metastasis in right iliac crest and 6th rib. The course of her disease was relentless. Although follicular thyroid carcinoma has an excellent prognosis, the presence of metastatic disease leads to a very dismal prognosis.
View complete article: PDF  |  Full-text

Late Cerebellar Vermis Metastasis of Breast Cancer Presenting as Pseudo-Benign Paroxysmal Positional Vertigo

Benign paroxysmal positional vertigo (BPPV) is a common peripheral vestibular disease; however intracranial lesions can mimic it. Intractable, not self-limiting paroxysmal positional vertigo sustained by intracranial tumors is called malignant paroxysmal positional vertigo (MPPV) while, when radiological imaging shows vascular cerebellar vermis lesions and there are atypical findings on the Dix-Hallpike maneuver, we speak about pseudo-benign paroxysmal type (pseudo-BPPV).
View complete article: PDF  |  Full-text

An Early Description of Carcinosarcoma in 1883

By 1804, John Abernethy was aware of the existence of a tumor which he called carcinomatous sarcoma. In this context, this paper presentshow, in 1883, David Finlay fully documented a case whose data were indicative of the formation of carcinosarcoma in a woman sufferingfrom fibroids.
View complete article: PDF  |  Full-text

Increased High Mobility Group Protein A2/SMAD3 Relates to Ovarian Cancer Progression

The high mortality associated with ovarian cancer is generally related to the development of drug-resistant disease. HMGA2 protein, a member of the high-mobility group AT-hook (HMGA) family of non-histone chromatin binding factors, is overexpressed in high-grade serous ovarian and tubal carcinomas, though little is known about its contribution to disease progression and drug resistance. We sought to assess whether compositional changes in HMGA2 production were associated with ovarian cancer progression.
View complete article: PDF  |  Full-text

Metastatic cancer of the pancreas: Historical review

During the 19th Century, there was a difficult choice concerning whether a pancreatic cancer is primary or secondary. However, in this paper, it is shown that some views were decidedly in favor of attack from other primaries. Indeed, the evidence of spread to the pancreas included either concise or coalescent lesions.
View complete article: PDF  |  Full-text

Acrometastasis from a Pancreatic Primary Adenocarcinoma: A First Report in the Literature

A seventy five year male presented with acute onset right foot pain and swelling. Plain imaging revealed a lytic area in the medial and middle cuneiform bones of the right foot. Background history of resected pancreatic cancer and current presentation were consistent early diffuse disease recurrence of a pancreatic primary tumour. The presenting feature in this case was of symptomatic acrometastases, that is, metastases to the feet.
View complete article: PDF  |  Full-text

Clinical Characteristics of Metastatic Gastric Tumors: A Report of 8 Cases in a Single Hospital

Metastatic gastric tumors (MGTs) mean the tumor cells that attack the stomach and grow there through blood vessel, lymph vessel, and other pathway, consistent with the primary tumor in phenotype, which are clinically uncommon, and information on MGTs is generally limited to single case reports. Here we present a clinical series of 8 cases with MGTs, in attention to discuss the clinical characteristics, diagnosis and treatment, and prognosis of MGTs.
View complete article: PDF  |  Full-text

Prostate Cancer – Double Vision but Solitary Lesion

A 53 year old man with a background of castrate-sensitive prostate cancer on intermittent androgen deprivation therapy (ADT) presented with right sixth nerve palsy secondary to a solitary right petroclival lesion involving adjacent dura and bone. The clinical and imaging characteristics of the lesion were consistent with a number of differential diagnoses (including metastatic prostate cancer, meningioma and chondrosarcoma).
View complete article: PDF  |  Full-text


Editorial Board Members Related to metastasis

Masayoshi Yamaguchi

Adjunct Professor
Department of Hematology and Biomedical Oncology
Emory University School of Medicine
United States

Ming Tan

Associate Professor
Mitchell Cancer Institute
United States

HONGYU LI

Associate Professor
Department of Gastroenterology
Shenyang Northern Hospital
China

Yajun Andrew Yi

Assistant Professor
Department of Bioinformatics
Vanderbilt University
United States

Jose Russo

Professor
Fox Chase Cancer Center
United States

Shen Hu

Associate Professor
School of Dentistry
University of California at Los Angeles
United States

Chunying Li

Assistant Professor
Department of Biochemistry and Molecular Biology
Wayne State University School of Medicine
United States

Tao Liu

Children's Cancer Institute
University of New South Wales
Australia

Lina H K LIM

Associate Professor
Department of Physiology
National University of Singapore
Singapore

MASAYOSHI YAMAGUCHI

Professor
Department of Hematology and Medical Oncology
Emory School of Medicine
Emory University
United States
Submit Manuscript